Related Experiment Video
Updated: Oct 10, 2025

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
LRRK2 signaling in neurodegeneration: two decades of progress
Lucia Iannotta1, Elisa Greggio1
1Department of Biology, University of Padova, Padova, Italy.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) is a complex GTPase/kinase orchestrating cytoskeletal dynamics and multiple steps of the endolysosomal pathway through interaction with a host of partners and phosphorylation of a subset of Rab GTPases. Mutations in LRRK2 cause late-onset Parkinson's disease (PD) and common variants in the locus containing LRRK2 have been associated with sporadic PD, progressive supranuclear palsy as well as a number of inflammatory diseases. This review encompasses the major discoveries in the field of LRRK2 pathobiology, from the initial gene cloning to the latest progress in LRRK2 inhibition as a promising therapeutic approach to fight neurodegeneration.
Insights
Leucine-rich repeat kinase 2 (LRRK2) is a key protein in cellular pathways. Understanding LRRK2
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is a complex GTPase/kinase.
- LRRK2 regulates cytoskeletal dynamics and the endolysosomal pathway.
- LRRK2 mutations are linked to Parkinson's disease (PD) and other neurodegenerative and inflammatory conditions.
Purpose of the Study:
- To review major discoveries in LRRK2 pathobiology.
- To highlight progress in LRRK2 inhibition for neurodegenerative diseases.
Main Methods:
- Literature review of LRRK2 research.
- Analysis of LRRK2's role in cellular pathways and disease.
Main Results:
- LRRK2 interacts with numerous partners and phosphorylates Rab GTPases.
- Genetic variations in LRRK2 are associated with sporadic PD and progressive supranuclear palsy.
- LRRK2 pathobiology research has advanced significantly.
Conclusions:
- LRRK2 is a critical protein in neurodegeneration.
- LRRK2 inhibition shows promise as a therapeutic strategy for PD and related disorders.
Related Concept Videos
Parkinson's Disease: Overview
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neural Regulation
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Lysosomal Hydrolases
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

